期刊文献+

突变选择窗理论及其应用

下载PDF
导出
摘要 近几十年来,关于细菌耐药性进展的报道越来越多,几乎涵盖了所有可利用的抗微生物药物[1]。Roberts等[2]在总结大量文献后指出,主要是不恰当的低剂量抗菌药导致了细菌耐药性和耐药率的上升,即人类的不合理用药导致细菌生长环境选择性压力剧增,从而迫使细菌不得不通过各种途径避免抗生素的伤害,以适应周围环境。近年来提出的细菌耐药突变选择窗(mutant selection window,MSW)理论从全新的角度认识细菌的耐药性。
出处 《交通医学》 2010年第1期26-28,共3页 Medical Journal of Communications
  • 相关文献

参考文献22

  • 1Demain AL, Sanchez S, Microbial drug discovery: 80 years of progress[J]. J Antibiot (Tokyo), 2009,62(1):5-16.
  • 2Roberts JA, Kruger P, Paterson DL, et al. Antibiotic resistance-what's dosing got to do with it[J]? Crit Care Med, 2008,36(8):2433-2440.
  • 3Dong Y, Zhao X, Domagala J, et al. Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium boris BCG and Staphylococcus aureus [J]. Antimicrob Agents Chemother, 1999,43(7):1756-1758.
  • 4Drlica K, Zhao X. Mutant selection window hypothesis updated[J]. Clin Infect Dis, 2007,44(5):681-688.
  • 5Smith HJ, Nichol KA, Hoban D J, et al. Stretching the mutant prevention concentration (MPC) beyond its limits [J]. J Antimicrob Chemother, 2003,51(6):1323-1325.
  • 6黄瀚,刘世坤.对抗菌药物防突变浓度及突变选择窗两概念的探讨与思索[J].中国临床药理学与治疗学,2008,13(1):21-24. 被引量:3
  • 7Zhao X. Clarification of MPC and the mutant selection window concept[J]. J Antimicrob Chemother, 2003,52(4):731.
  • 8刘同华,邢茂,宋光伟,王涵.细菌耐药突变选择窗理论的研究与应用[J].药学服务与研究,2009,9(1):9-12. 被引量:6
  • 9Aubert G, Carricajo A, Fonsale N, Vautrin AC. Optimization of the use of ciprofloxacin[J]. Pathol Biol (Paris), 2008,57(3): 236-239.
  • 10崔俊昌,陈良安.细菌耐药突变选择窗与合理用药[J].中华老年多器官疾病杂志,2007,6(5):293-295. 被引量:4

二级参考文献73

  • 1何礼贤.呼吸机相关肺炎的研究近况[J].临床内科杂志,2004,21(10):658-660. 被引量:23
  • 2袁斌,刘贵昌,徐磊.铜离子杀菌剂灭活SRB的研究[J].腐蚀与防护,2005,26(5):187-188. 被引量:6
  • 3崔俊昌,刘又宁,王睿,梁蓓蓓,郑专杰.氟喹诺酮类药物对临床分离金黄色葡萄球菌的防耐药变异浓度[J].中华医院感染学杂志,2005,15(6):611-614. 被引量:10
  • 4李朝霞,刘又宁,王睿,童卫杭,程仕虎.几种抗菌药物在不同浓度时对金黄色葡萄球菌耐药突变株选择的影响[J].中国临床药理学与治疗学,2007,12(2):163-167. 被引量:12
  • 5Zhao Xi lin, Drlica K. Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies[J]. Clin Infect Dis, 2001, 33(Suppl 3): S147-S156.
  • 6Zhao Xi-lin, Drlica K. Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window[J].J Infect Dis, 2002, 185(4) : 561-565.
  • 7Drlica K. A strategy for fighting antibiotic resistance[J]. ASM News, 2001, 67(1): 27-33.
  • 8Drlica K. The mutant selection window and antimicrobial resistance[J]. J Antimicrob Chemother, 2003, 52(1): 11-17.
  • 9Dong Yu zhi, Zhao Xi-lin, Domagala J, etal. Effect of fluo roquinolone concentration on selection of resistant mutants of Mycobacterium boris BCG and Staphylococcus aureus [J]. Antimierob Agents Chemother, 1999, 43(7): 1756-1758.
  • 10Dong Yu-zhi, Zhao Xi lin, Kreiswirth B N, et al. Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis [J].Antimicrob Agents Chemother, 2000, 44 (9) : 2581- 2584.

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部